Capivasertib (Standard)
Capivasertib (Standard) is the analytical standard of Capivasertib. This product is intended for research and analytical applications. Capivasertib (AZD5363) is an orally active and potent pan-AKT kinase inhibitor with IC50 of 3, 7 and 7 nM for Akt1, Akt2 and Akt3, respectively.
Product Specifications
CAS Number
1143532-39-1
UNSPSC
12352100
Target
Akt; Autophagy; Reference Standards
Related Pathways
Autophagy; Others; PI3K/Akt/mTOR
Field of Research
Cancer
Smiles
O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO
Molecular Formula
C21H25ClN6O2
Molecular Weight
428.92
References & Citations
[1]Davies BR, et al. Preclinical pharmacology of AZD5363, an inhibitor of AKT: pharmacodynamics, antitumor activity, and correlation of monotherapy activity with genetic background. Mol Cancer Ther. 2012 Apr;11 (4) :873-87.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC941953-500 1x 500 µL
CD21 (Mature B-Cell & Follicular Dendritic Cell Marker) (CR2/1953), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNCB1665-100 1x 100 µL
Wilm's Tumor 1 (WT1) (Wilm's Tumor & Mesothelial Marker), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
![2-[1-(4-Piperonyl)piperazinyl]benzothiazole](https://cdn.genprice.uk/products/572/2467794556147/imageurl/trc-p490503-10mg.webp)
